|A family of human cdc2-related protein kinases.
|Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
|Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells.
|Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a.
|Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.
|Structural basis for CDK6 activation by a virus-encoded cyclin.
|Human chromosome 7: DNA sequence and biology.
|CDK6 blocks differentiation: coupling cell proliferation to the block to differentiation in leukemic cells.
|The DNA sequence of human chromosome 7.
|Complete sequencing and characterization of 21,243 full-length human cDNAs.
|Cyclin-dependent kinase 6 inhibits proliferation of human mammary epithelial cells.
|Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6.
|The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
|Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.
|Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin.
|Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.
|Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6.
|Beyond the cell cycle: a new role for Cdk6 in differentiation.
|Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential cellular gene expression in response to enterovirus 71 infection.
|Toward understanding the structural basis of cyclin-dependent kinase 6 specific inhibition.
|Patterns of somatic mutation in human cancer genomes.
|CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms.
|Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPalpha interaction.
|A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A.
|Cell cycle, CDKs and cancer: a changing paradigm.
|Large-scale proteomics analysis of the human kinome.
|Lysine acetylation targets protein complexes and co-regulates major cellular functions.
|Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
|Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
|Induction of human beta-cell proliferation and engraftment using a single G1/S regulatory molecule, cdk6.
|4-(Pyrazol-4-yl)-pyrimidines as selective inhibitors of cyclin-dependent kinase 4/6.
|Initial characterization of the human central proteome.
|N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.
|CDK6 associates with the centrosome during mitosis and is mutated in a large Pakistani family with primary microcephaly.